sitosterol, beta-
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 20, 2010 (NCT01053065)
Timeline
No events for the selected filters.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108117 ↗
Also known as
- 24-ethyl-5-cholesten-3 beta-ol
- 24-ethylcholest-5-en-3 beta-ol
- 24-ethylcholesterol
- (3beta,24s)-stigmast-5-en-3-ol
- 3beta-sitosterol
- 3beta-stigmast-5-en-3-ol
- 5-stigmasten- 3 beta-ol
- alpha-dihydrofucosterol
- angelicin
- azuprostat
- betaprost
- beta-sitosterin
- beta-sitosterol
- beta-sitosterol
- clionasterol
- cytellin
- cytellin
- cytellin
- gamma-sitosterol
- harzol
- prostasal
- quebrachol
- sitosterol
- sitosterol
- sitosterol
- sitosterol
- sitosterol
- sitosterol
- sitosterol, 26-(14)c-labeled
- sitosterol, (3beta,24xi)-isomer
- sitosterol, (3beta)-isomer
- sitosterol, beta-
- sitosterols
- sitosterols
- stigmast-5-en-3-ol, (3beta,24s)-
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03681392 | N/A | Jan 31, 2019 | Dr. Pyke's Supplements |
| NCT01053065 | N/A | Jan 20, 2010 | Biomedical Foundation for Cardiovascular Research of Padova, Pfizer, University of Padova, University of Padua |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomedical Foundation for Cardiovascular Research of Padova | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Dr. Pyke's Supplements | For profit | 1 | 1 | 1 | 2019 |
| Pfizer | For profit | 1 | 0 | 1 | 2010 |
| University of Padova | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Padua | Academic/Hospital | 1 | 1 | 1 | 2010 |
5 organizations
Page 1 / 1